Pharmaceutical compositions comprising 4-(6Br,10aS)-3-methyl-2, 3, 6b, 9, 10, 10a-hexahydro… Grant US-11680065-B2 United States of America 20 Jun 2023
METHODS FOR TREATING RESIDUAL SYMPTOMS OF SCHIZOPHRENIA Grant EP-3076967-B1 European Patent Office 28 Jul 2021